• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53肿瘤抑制因子在人乳腺组织、原位肿瘤及体外肿瘤中的表达模式。

Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro.

作者信息

Bártek J, Bártková J, Vojtĕsek B, Stasková Z, Rejthar A, Kovarík J, Lane D P

机构信息

Research Institute of Clinical and Experimental Oncology, Brno, Czechoslovakia.

出版信息

Int J Cancer. 1990 Nov 15;46(5):839-44. doi: 10.1002/ijc.2910460515.

DOI:10.1002/ijc.2910460515
PMID:2228312
Abstract

An extensive series of histological sections reflecting the various states of normal breast tissue, and a range of benign and malignant lesions, were examined for the expression of the p53 protein using a panel of anti-p53 antibodies. In 2 separate series the results of using frozen or methacarn-fixed, paraffin-embedded sections were compared. Strong positive staining for p53 was detected in over 50% of the malignant lesions when frozen sections were used. This number fell to just over 20% when methacarn-fixed sections were examined. In neither series was any p53 staining seen in normal breast or in the benign lesions. Studies by Western blotting on breast cell lines confirmed that this histological signal is due to a pronounced over-expression of the p53 protein. Earlier studies show that this over-expression is associated with mutation of the p53 gene. Mutation of the p53 gene with over-expression of the mutant protein is therefore one of the most frequent specific genetic changes in malignant breast cancer.

摘要

使用一组抗p53抗体,对一系列反映正常乳腺组织不同状态以及一系列良性和恶性病变的组织学切片进行p53蛋白表达检测。在两个独立的系列中,对使用冷冻切片或甲醇 Carnoy 固定、石蜡包埋切片的结果进行了比较。当使用冷冻切片时,超过50%的恶性病变中检测到p53强阳性染色。当检查甲醇 Carnoy 固定切片时,这一数字降至略高于20%。在这两个系列中,正常乳腺或良性病变中均未见到任何p53染色。对乳腺细胞系进行的蛋白质印迹研究证实,这种组织学信号是由于p53蛋白明显过度表达所致。早期研究表明,这种过度表达与p53基因突变有关。因此,p53基因突变伴突变蛋白过度表达是恶性乳腺癌中最常见的特定基因变化之一。

相似文献

1
Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro.p53肿瘤抑制因子在人乳腺组织、原位肿瘤及体外肿瘤中的表达模式。
Int J Cancer. 1990 Nov 15;46(5):839-44. doi: 10.1002/ijc.2910460515.
2
p53 mutations and expression in breast carcinoma in situ.原位乳腺癌中的p53突变与表达
Am J Pathol. 2000 Jan;156(1):183-91. doi: 10.1016/S0002-9440(10)64718-9.
3
Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status.人乳腺癌中MDM2基因的扩增及其与MDM2和p53蛋白状态的关联。
Br J Cancer. 1995 May;71(5):981-5. doi: 10.1038/bjc.1995.189.
4
Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease.从良性乳腺疾病向恶性乳腺疾病转变过程中突变型p53蛋白的免疫组化表达及核DNA含量
Hum Pathol. 1994 Nov;25(11):1228-33. doi: 10.1016/0046-8177(94)90040-x.
5
Molecular and immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancer.乳腺原位癌及浸润癌刮片和组织中p53基因突变的分子及免疫组化分析
Virchows Arch. 1997 Dec;431(6):375-81. doi: 10.1007/s004280050114.
6
Tumor cell-specific loss of p53 protein in a unique in vitro model of human breast tumor progression.
Carcinogenesis. 1994 Sep;15(9):1969-73. doi: 10.1093/carcin/15.9.1969.
7
Mutant p53 protein in serum could be used as a molecular marker in human breast cancer.血清中的突变型p53蛋白可作为人类乳腺癌的分子标志物。
Int J Oncol. 2006 Apr;28(4):995-1002. doi: 10.3892/ijo.28.4.995.
8
Expression of calcium-binding protein S100A2 in breast lesions.钙结合蛋白S100A2在乳腺病变中的表达。
Br J Cancer. 2000 Dec;83(11):1473-9. doi: 10.1054/bjoc.2000.1488.
9
Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.p53癌蛋白的异常表达是多种人类恶性肿瘤的共同特征。
Oncogene. 1991 Sep;6(9):1699-703.
10
Maintenance of p53 alterations throughout breast cancer progression.在乳腺癌整个进展过程中p53改变的维持。
Cancer Res. 1991 May 15;51(10):2605-10.

引用本文的文献

1
A new function for the serine protease HtrA2 in controlling radiation-induced senescence in cancer cells.丝氨酸蛋白酶 HtrA2 的新功能可控制癌细胞中的辐射诱导衰老。
Mol Oncol. 2022 Mar;16(6):1365-1383. doi: 10.1002/1878-0261.13187. Epub 2022 Feb 16.
2
Evaluation of the Role of p53 Tumour Suppressor Posttranslational Modifications and TTC5 Cofactor in Lung Cancer.评估抑癌基因 p53 翻译后修饰和 TTC5 共因子在肺癌中的作用。
Int J Mol Sci. 2021 Dec 7;22(24):13198. doi: 10.3390/ijms222413198.
3
Genetic alterations in Japanese extrahepatic biliary tract cancer.
日本肝外胆管癌的基因改变。
Oncol Lett. 2017 Jul;14(1):877-884. doi: 10.3892/ol.2017.6224. Epub 2017 May 22.
4
Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53.野生型和癌症相关突变型p53的转录调控
Cold Spring Harb Perspect Med. 2017 Feb 1;7(2):a026054. doi: 10.1101/cshperspect.a026054.
5
Somatic TP53 Mutations in the Era of Genome Sequencing.基因组测序时代的体细胞TP53突变
Cold Spring Harb Perspect Med. 2016 Nov 1;6(11):a026179. doi: 10.1101/cshperspect.a026179.
6
Genetic Instability and Disease Prognostication.遗传不稳定性与疾病预后评估
Recent Results Cancer Res. 2015;200:81-94. doi: 10.1007/978-3-319-20291-4_4.
7
p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast.p53 突变在经典型和多形性浸润性小叶癌中的研究。
Cell Oncol (Dordr). 2012 Apr;35(2):111-8. doi: 10.1007/s13402-012-0071-y. Epub 2012 Feb 22.
8
A Cohort Study of p53 Mutations and Protein Accumulation in Benign Breast Tissue and Subsequent Breast Cancer Risk.p53 基因突变和蛋白蓄积在良性乳腺组织与随后乳腺癌风险的队列研究。
J Oncol. 2011;2011:970804. doi: 10.1155/2011/970804. Epub 2011 Aug 22.
9
Immunohistochemical detection of p53 protein in basal cell skin cancer after microwave-assisted antigen retrieval.微波辅助抗原修复后基底细胞皮肤癌中p53蛋白的免疫组织化学检测
J Mol Histol. 2009 Feb;40(1):13-21. doi: 10.1007/s10735-008-9208-8. Epub 2008 Dec 19.
10
Biological indices in the assessment of breast cancer.评估乳腺癌的生物学指标。
Clin Mol Pathol. 1995 Oct;48(5):M221-38. doi: 10.1136/mp.48.5.m221.